Foster Victor Wealth Advisors, LLC Vertex Pharmaceuticals Inc Transaction History

Foster Victor Wealth Advisors, LLC

$1.38 Billion
Q3 2024

A detailed history of Foster Victor Wealth Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Foster Victor Wealth Advisors, LLC holds 21,526 shares of VRTX stock, worth $8.84 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

21,526

Previous 30,587 29.62%

Holding current value

$8.84 Million

Previous $14.3 Million 30.17%

% of portfolio

0.72%

Previous 1.13%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$460.0 - $505.78 $4.17 Million - $4.58 Million	-9,061 Reduced 29.62%	21,526 $10 Million
Q2 2024 Jul 18, 2024	SELL	$392.81 - $485.53 $1.25 Million - $1.55 Million	-3,183 Reduced 9.43%	30,587 $14.3 Million
Q1 2024 Apr 26, 2024	BUY	$407.69 - $446.08 $1.17 Million - $1.28 Million	2,867 Added 9.28%	33,770 $14.1 Million
Q4 2023 Jan 19, 2024	SELL	$343.0 - $410.68 $557,032 - $666,944	-1,624 Reduced 4.99%	30,903 $12.6 Million
Q3 2023 Oct 13, 2023	BUY	$338.18 - $362.46 $6.19 Million - $6.64 Million	18,309 Added 128.77%	32,527 $11.3 Million
Q2 2023 Jul 14, 2023	BUY	$314.42 - $351.91 $144,004 - $161,174	458 Added 3.33%	14,218 $5 Million
Q1 2023 Apr 20, 2023	BUY	$283.23 - $323.1 $146,713 - $167,365	518 Added 3.91%	13,760 $4.34 Million
Q4 2022 Jan 27, 2023	SELL	$285.76 - $321.48 $174,027 - $195,781	-609 Reduced 4.4%	13,242 $0
Q3 2022 Oct 24, 2022	SELL	$273.83 - $305.53 $88,720 - $98,991	-324 Reduced 2.29%	13,851 $4.14 Million
Q2 2022 Jul 19, 2022	SELL	$234.96 - $292.55 $836,927 - $1.04 Million	-3,562 Reduced 20.08%	14,175 $4.13 Million
Q1 2022 Apr 14, 2022	SELL	$221.42 - $260.97 $1.15 Million - $1.36 Million	-5,196 Reduced 22.66%	17,737 $4.83 Million
Q4 2021 Jan 19, 2022	BUY	$177.01 - $223.45 $375,438 - $473,937	2,121 Added 10.19%	22,933 $5.19 Million
Q3 2021 Oct 08, 2021	BUY	$181.39 - $202.99 $284,600 - $318,491	1,569 Added 8.15%	20,812 $3.78 Million
Q2 2021 Jul 29, 2021	BUY	$187.49 - $221.1 $892,452 - $1.05 Million	4,760 Added 32.87%	19,243 $3.88 Million
Q1 2021 Apr 23, 2021	BUY	$207.02 - $241.31 $3 Million - $3.49 Million	14,483 New	14,483 $3.13 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster Victor Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foster Victor Wealth Advisors, LLC with notifications on news.

Account

Foster Victor Wealth Advisors, LLC Vertex Pharmaceuticals Inc Transaction History